Cargando…
Global antibiotic use during the COVID-19 pandemic: analysis of pharmaceutical sales data from 71 countries, 2020–2022
BACKGROUND: Despite bacterial coinfection rates of less than 10%, antibiotics are prescribed to an estimated 75% of patients with COVID-19, potentially exacerbating antimicrobial resistance. We estimated the associations of COVID-19 cases and vaccinations with global antibiotic sales during the firs...
Autores principales: | Nandi, Arindam, Pecetta, Simone, Bloom, David E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900305/ https://www.ncbi.nlm.nih.gov/pubmed/36776504 http://dx.doi.org/10.1016/j.eclinm.2023.101848 |
Ejemplares similares
-
Community level antibiotic utilization in India and its comparison vis-à-vis European countries: Evidence from pharmaceutical sales data
por: Farooqui, Habib Hasan, et al.
Publicado: (2018) -
Global sales of oral antibiotics formulated for children
por: Li, Grace, et al.
Publicado: (2020) -
The Pharmaceutical Society and the Sale of Laudanum
Publicado: (1916) -
Effect of the economic recession on pharmaceutical policy and medicine sales in eight European countries
por: Leopold, Christine, et al.
Publicado: (2014) -
Timing of non-pharmaceutical interventions to mitigate COVID-19 transmission and their effects on mobility: a cross-country analysis
por: Summan, Amit, et al.
Publicado: (2021)